Skip to main content

Table 3 Cox Regression Analysis of Association between Clinical Risk Factors and Incidence of Hypertension

From: Incidence of hypertension among persons living with HIV in China: a multicenter cohort study

Covariate

Univariate model

HR (95% CI)

P value

Multivariable model

HR (95% CI)

P value

Male

1.14 (0.80, 1.62)

0.47

  

Age (per year increase)

1.04 (1.03, 1.05)

< 0.001

1.02 (1.00, 1.03)

0.06

BMI (per kg/m2increase)

1.09 (1.04, 1.14)

< 0.001

1.07 (1.01, 1.13)

0.02

Han ethnicity

1.27 (0.80, 2.02)

0.32

  

Current smoking

0.84 (0.59, 1.21)

0.35

  

Current alcohol use

0.83 (0.58, 1.18)

0.30

  

eGFR (per ml/min increase)

0.99 (0.98, 1.00)

< 0.01

NA

NA

Diabetes

1.19 (0.61, 2.32)

0.62

  

TC > 5.2 (mmol/l)

1.24 (0.79, 1.96)

0.36

  

TG > 1.7 (mmol/l)

1.18 (0.86, 1.63)

0.31

  

HDL-c < 1.0 (mmol/l)

1.22 (0.90, 1.67)

0.20

  

LDL-c > 4.1(mmol/l)

1.42 (0.45, 4.45)

0.55

  

Dyslipidemia

1.28 (0.95, 1.73)

0.11

  

HBs Ag+

1.16 (0.74, 1.82)

0.51

  

HCV-Ab+

1.69 (1.05, 2.72)

0.03

NA

NA

Route of HIV transmission

  

NA

NA

 Heterosexual

0.99 (0.55, 1.80)

0.98

  

 MSM

1.21 (0.67, 2.17)

0.53

  

 Blood transfusion

4.12 (2.08, 8.19)

< 0.001

  

 Others

Reference

   

Years since HIV diagnosis

(per year increase)

1.06 (0.97, 1.14)

0.19

  

Baseline CD4+ cell count

(per cells/mm3increase)

0.999 (0.997, 1.000)

0.03

1.003 (1.001, 1.004)

< 0.01

Baseline HIV Viral load

(per log10 copies/ml increase)

0.97 (0.74, 1.27)

0.82

  

Stavudine exposure

1.92 (1.42, 2.60)

< 0.001

NA

NA

Zidovudine exposure

0.50 (0.36, 0.71)

< 0.001

0.15 (0.10, 0.24)

< 0.001

TDF exposure

0.46 (0.33, 0.64)

< 0.001

0.13 (0.08, 0.21)

< 0.001

Recent CD4+ cell count

(per cells/mm3increase)

0.996 (0.995, 0.997)

< 0.001

  

Recent CD4+/CD8+ ratio

0.09 (0.05, 0.17)

< 0.001

0.14 (0.06, 0.31)

< 0.001

Recent VL

(per log10 copies/ml increase)

1.87 (1.65, 2.12)

< 0.001

1.28 (1.08, 1.51)

< 0.01

  1. Abbreviations: HR Hazard ratio; CI confidence interval; NA not available; BMI body mass index; TC total cholesterol; TG triglycerides; HDL-c high-density lipoprotein cholesterol; LDL-c low-density lipoprotein cholesterol; HBsAg+ hepatitis B surface antigen; HCV Ab hepatitis C antibody; HIV human immunodeficiency virus; MSM men who have sex with men; TDF tenofovir disoproxil fumarate; VL HIV-1 viral load